The Evolving Concept of Susceptibility in Risk Assessment

Similar documents
PRINCIPLES AND GUIDELINES FOR THE CONDUCT OF MICROBIOLOGICAL RISK ASSESSMENT CAC/GL Adopted Amendments 2012, 2014.

Outline of Risk Assessment Training and Experience (RATE): Basic Understanding and Application of Risk Assessments

Harmonisation of Human and Ecological Risk Assessment of Chemical Mixtures at EFSA

Tools for Prioritizing Food Safety Concerns: An FDA Perspective

Non-Chemical Stressors and Cumulative Risk Assessment: An Overview of Current Initiatives and Potential Air Pollutant Interactions

Health-based targets should assist The judgement of safety or what is a

Current State of the Science in Chemical Risk Assessment

BIOSAFETY AND ENVIRONMENTAL ISSUES

ENVIRONMENTAL REGULATIONS AND STANDARD SETTING Environmental Quality Standards - P. D. Kalabokas, M.N. Christolis and N.C.

Draft Guidance for Industry Development and Use of Risk Minimization Action Plans

Problem Formulation and Conceptual Model Development for Aquatic Placement

APEC ACTIONS ON PUBLIC CONSULTATION IN THE IN INTERNET ERA JENNIFER STRADTMAN OFFICE OF THE U.S. TRADE REPRESENTATIVE DECEMBER 10, 2014

PAN Europe s briefing on:

Ecological Risk Assessment and the Tittabawassee River, Why, How and Who Cares

FDA Guidance, Clinical Pharmacology, and Regulatory Science

PUBLIC CONSULTATION AT STEP 4 OF THE VICH PROCEDURE OVERVIEW OF COMMENTS RECEIVED

Ethical Principles in Clinical Research

GUIDANCE ON RISK ASSESSMENT OF LIVING MODIFIED ORGANISMS AND MONITORING IN THE CONTEXT OF RISK ASSESSMENT

The role of the health sector in the Strategic Approach to International Chemicals Management towards the 2020 goal and beyond

Advancing Regulatory Science for Medical Countermeasures Development: An Institute of Medicine Workshop

Joint Evaluation of Joint Programmes on Gender Equality in the United Nations System Management Response

Aligning Safe Food Production to Risk - Based Food Safety Management

UNITED STATES DEPARTMENT OF AGRICULTURE FOOD SAFETY AND INSPECTION SERVICE WASHINGTON, DC USE OF MICROBIAL PATHOGEN COMPUTER MODELING IN HACCP PLANS

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1

6.3.2 Exposure Assessment

The Precautionary Principle and Protection of Children s s Health

MICROBIO, IMMUN, PATHOLOGY-MIP (MIP)

GRU MPH Core & Concentration Specific Competency Matrix (Last Updated: March 31, 2015)

SUSTAINABLE DEVELOPMENT AND POVERTY ALLEVIATION EXPLORING THE LINKS. Anantha Kumar Duraiappah - IISD

Malaria Research Capability Strengthening in Africa

Development of Remediation Targets for Contaminated Land

Horticulture Research in Europe to 2020 and beyond

Importance of Pharmacovigilance for Pharmaceutical Industry

FUSRAP COST TO COMPLETE. Kate Peterson U.S. Army Corps of Engineers HTRW CX, Omaha District Omaha, NE 68144

Health Effects of Pharmaceuticals in the Water Supply: A Knowledge Synthesis

Early Development Best Practices for Stability- Regulatory Perspective

CRITICAL ROLES OF WATER IN ACHIEVING PERSPECTIVE [WATER-ENERGY-FOOD- THE PROPOSED SDGS: A NEXUS CLIMATE CHANGE]

RAISING THE STANDARD THE NEW ISO RISK MANAGEMENT STANDARD

Chemical Constituents in Coal Combustion Residues: Risks and Toxicological Updates

Department of Environmental & Occupational Health Department of Global Health

Integrated Water Resources Management

Development of Guidance for the. Environmental Risk Assessment (ERA) Environmental risk assessment of plant pests by

Challenges in Antimicrobial Clinical Development. Axel Dalhoff & Heino Staß Institut für Klinische Pharmakologie Bayer AG, Wuppertal, D

Asset Risk Management Journey Plan

The KIDSNET Concept:

Crowe Critical Appraisal Tool (CCAT) User Guide

Chapter 6: Person-Based Pay Structures

Exposure Assessment Choosing the Right Approach

Immunotoxicology Technical Committee (ITC) HESI Assembly of Members January 19, 2009

Wildlife Health Risk Assessment in Support of Decisions and Policies

Environmental justice and interpretation of human biomonitoring results

Drug Development: Why Does it Cost so Much? Lewis J. Smith, MD Professor of Medicine Director, Center for Clinical Research Associate VP for Research

Paradigm Change in Manufacturing Operations SM

Research Scientist (Various Specialties) Series

Moving Towards Sustainable Remediation: Optimization Concepts and Strategy

Human Health and Ecological Risk Assessment with Spatial Analysis and Decision Assistance (SADA) Freeware

ISO 22000:2005 SYSTEMKARAN ADVISER & INFORMATION CENTER SYSTEM KARAN ADVISER & INFORMATION CENTER FOOD SAFETY MANAGEMENT SYSTEM ISO 22000:2005

Regulatory Pathways for Rare Diseases

Weight of Evidence Determinations for EPA s EDSP ISRTP Workshop, December 13 Lister Hill Auditorium, Bethesda, MD

LINEE GUIDA IN MEDICINA. Corso di Informatica Medica

Mitochondrial Manipulation Technologies: Preclinical Considerations

INTRODUCTION. Assess how proposals will affect all members of the community, particularly the most vulnerable.

Chapter 6 Risk Characterization

Risk Assessment of Occupational Exposures & Work Environment Dr Sharon East-Miles Consultant Occupational Physician Winchester Surgical & Medical

Long-Range Research Initiative Global Research Strategy. 21st Century Approaches to Risk Sciences

Managing Risk and Uncertainty Through the Drug Life cycle. Recent FDA Initiatives. Theresa Mullin, PhD

MIRMAP Modelling Instantaneous Risk for Major Accident Prevention. Stein Haugen Department of Marine Technology NTNU

QbD approach and Regulatory Challenges in Europe

Draft agreed by SWP, vswp and GMP/GDP Inspectors WG September Adopted by CVMP for release for consultation 8 November 2016

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

USEPA Research Activities to Characterize Children s Environmental Exposures

INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY Project on the Harmonization of Approaches to the Assessment of Risk from Exposure to Chemicals

Health Effects Associated with Stack Chemical Emissions from NYS Natural Gas Compressor Stations:

School of Public Health and Health Services Department of Environmental & Occupational Health Department of Global Health

Characterization of Biotechnology Products: A Regulatory Perspective

Example of research about links between, health, environment and vulnerabilities

Short Course: Adaptive Clinical Trials

UNISDR Science and Technology Conference on the implementation of the Sendai Framework for Disaster Risk Reduction

Introduction. Seafood HACCP Alliance Training Course 3-1

Organization Culture Dimensions as Antecedents of Internet Technology Adoption

A Multi-Factorial Risk Prioritization Framework for Food-borne Pathogens

Summary of Provisions in 21 st Century Cures Act (H.R. 6) as passed by full House of Representatives, July 10, 2015

National Standard for Environmental Risk Management of Industrial Chemicals

NATIONAL PRIORITIES:

A Framework for Risk Characterization of Environmental Pollutants

Reporting Results and Incidental Findings to Research Participants

QbD (Quality by Design) Has industry benefited from this? WHITE PAPER.

TOP 10 INVESTIGATOR RESPONSIBILITIES WHEN CONDUCTING HUMAN SUBJECTS RESEARCH

Top Ten Investigator Responsibilities When Conducting Human Subjects Research

Mathematical Modeling of Tuberculosis

Probabilistic Safety Assessment Safety & Regulatory Framework

Utilizing Innovative Statistical Methods. Discussion Guide

Introduction to Health Impact Assessment

Core Competencies for Public Health Professionals

Course Descriptions. BIOL: Biology. MICB: Microbiology. [1]

COMPREHENSIVE DRINKING WATER SOURCE-TO-TAP ASSESSMENT GUIDELINE

Transcription:

The Evolving Concept of Susceptibility in Risk Assessment Rebecca Parkin, PhD, MPH School of Public Health and Health Services The George Washington University Washington, DC Jan 20, 2010 FDA Workshop 1

Outline 1. What is susceptibility (S)? 2. Where is S addressed in risk assessment (RA)? Chemical Microbial 3. How is S addressed in RA? 4. What are the S issues in RA? 5. Conclusions 2

1. What is Susceptibility? Many discipline-based variations, emphases Ecology: organism level, sensitive to poison Medicine: host physiology, individual scale Epidemiology: intrinsic and acquired host traits, dysfunction relative to other individuals or populations Toxicology: probability and extent of response conditional on exposure, population scale, sensitive or vulnerable Parkin and Balbus, 2000 3

But All definitions of susceptibility include 3 components Physiological state of the host Relational construct between the host and an external agent Change in the host resulting from contact with the agent Change is usually, but not always, adverse

Fostering Confusion Susceptibility is used interchangeably with other terms Sensitive Vulnerable However, there are definitional differences that matter Balbus and Parkin, 2000 5

Susceptibility vs. Sensitivity Susceptibility is: A capacity leading to higher risk at a given exposure level, due to biological (intrinsic) factors that can modify the effect of a specific exposure Sensitivity is: A capacity for higher risk due to the combined effect of susceptibility (biological factors) and differences in exposure Makri et al, 2004 6

Vulnerability Definitions focus on the capacity to be harmed or injured WHO attributes vulnerability (V) to both Intrinsic (biological) factors and Extrinsic (environmental, behavioral) factors And states that V is S + environmental and behavioral factors However, no formal definition for RA WHO Guidance, 2010 pending 7

Susceptibility vs. Vulnerability Susceptibility Includes intrinsic factors only Characteristic of an individual Defined by the host Vulnerability Includes intrinsic and extrinsic factors Characteristic of an individual or a group Defined by the host (behavior) and environment WHO, 2010 pending 8

Susceptibility is Part of Vulnerability Modified from de Roda Husman, 2008 9

Key Conceptual Issues in Framing Susceptibility for RA Individual vs. population scale Intrinsic and/or extrinsic factors Intrinsic and exposure pathway (behavior) affect host s probability and severity of response (Embrey et al, 2003) Rely on host descriptors 10

2. Where is Susceptibility Addressed in RA? Typically in the Dose-Response (D-R) step of RA Emphasis is on host characteristics Usually these characteristics are not explicitly linked to susceptibility Sometimes host-agent relationship traits are noted 11

3. How is Susceptibility Addressed in RA? Lists of subpopulations based on observable characteristics May be mandated in laws, regulations E.g., children, pregnant women, elderly Different human health outcomes &/or severity based on the literature E.g., More severe Cryptosporidiosis among the immunecompromised individuals Separate D-R curves are sometimes used 12

FDA s RA Framework Hazard Identification Problem Formulation Dose Response Assessment Risk Characterization Exposure Assessment Modified NRC, 1983 13

How is Susceptibility Handled in the FDA Framework? Primarily in the Dose-Response (Hazard Characterization) step Subpopulations are modeled separately Dose-response curves are developed for each group based on animal and human data Distributions are adjusted for variability in host susceptibility Distributions are combined in Risk Characterization to create a probabilistic estimate for the entire population 14

ILSI s Microbial RA Framework Problem Formulation Analysis Risk Characterization Problem Definition Preliminary Risk Assessment Exposure Characterization Health Effects Characterization Risk Estimation Risk Description ILSI, 2000 15

How is Susceptibility Addressed in the ILSI Framework? Susceptibility is not highlighted as a key issue Primarily appears in the Dose-Response step within Health Effects Characterization Emphasis is on host characteristics Other elements related to the pathogen and the hostpathogen relationship are in other components of the paradigm These are not explicitly linked to susceptibility 16

Ex.: Addressing Susceptibility Analysis of 9 food-borne microbial pathogen RAs that included S (all in the D-R step) Explicit decisions Age groups as S subgroups: 5 of 9 MRAs More severe outcomes in S subgroups: 4 of 9 No differences in S within subgroups: 2 of 9 Implicit assumptions No impacts of gender or genetic differences No differences in S within subgroups Parkin, 2008 17

But Only 1 MRA explicitly defined susceptibility Host capacity to defend against the pathogen 5 of the 9 MRAs addressed susceptibility in all steps of the RA Mostly by using recognizable subgroups 18

4. What are the Susceptibility Issues in RA? Susceptibility is a complex concept Can we agree on 1 conceptual definition for RA? How explicitly can S be defined for a RA? Agent, host (scale), outcome/s, severity Available knowledge and data Can it be used comprehensively & systematically in RA? Not always fully addressed in all RA steps Is the conceptual base incomplete, vague? 19

What is the Scope of Susceptibility? Population as a whole or subpopulations? How should variability be handled within either choice? Specific location? Region as general population reference point? Specific outcome/s? Acute, chronic, sequelae? Differential outcomes and/or severity? 20

From Susceptibility Concept to Analytic Approach What are the key factors (source to effects)? Relationships between them? Can they be diagrammed? Are there differential exposure pathways, probabilities? Are there sufficient data to translate the conceptual model into a complete analytic model for S? What are the gaps in knowledge, data? What assumptions, defaults are needed? Separate dose-response curves desirable and feasible? 21

Evaluate the Susceptibility Results What impacts did the design choices have? How did the data quality affect the susceptibility results? How did the assumptions and defaults affect the susceptibility conclusions? Were the key sources of uncertainty and variability identified for S subgroups? Were the susceptibility issues in the problem statement adequately addressed? 22

Recommendations Explicitly define susceptibility in the problem formulation and add S decisions to RA scope Draft a comprehensive conceptual diagram to Place the S concept throughout the RA steps Organize available data and evaluate data quality Identify gaps in knowledge and evidence Determine needed assumptions and defaults Design an operational analytic approach Evaluate and explicitly link the S results back to the problem statement 23

5. Conclusions So where are we with the concept of susceptibility? Still evolving stay tuned! Definitions for specific RAs will always differ Legal mandates Available data and analytic feasibility However, Consensus about the concept for use in RA would improve communication across disciplines. 24

Thank You! 25